Glucocorticoids Toxicity
Showing 1 - 25 of 6,157
Glucocorticoids Toxicity, Iatrogenic Effect Trial (Prednisolone, Placebo)
Not yet recruiting
- Glucocorticoids Toxicity
- Iatrogenic Effect
- Prednisolone
- Placebo
- (no location specified)
Nov 21, 2023
Patients Followed In Rheumatology Clinic
Recruiting
- Glucocorticoids Toxicity
- +3 more
-
Ankara, TurkeyHacettepe University
Aug 1, 2022
PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS
Recruiting
- Inflammatory Rheumatism
- +5 more
-
Angers, France
- +9 more
May 4, 2022
Glucocorticoids Toxicity, COVID-19, Infectious Disease Trial in Bangalore (101-PGC-005)
Active, not recruiting
- Glucocorticoids Toxicity
- +3 more
-
Bangalore, Karnataka, IndiaICBio Clinical Research Pvt. Ltd.
Dec 13, 2022
Glucocorticoids Toxicity, Glucose Intolerance Trial in Nashville (Prednisone)
Completed
- Glucocorticoids Toxicity
- Glucose Intolerance
-
Nashville, TennesseeVanderbilt University Medical Center -CRC
May 25, 2020
Systemic Lupus Erythematous (SLE) Trial run by the NIAMS (SOLU-MEDROL)
Recruiting
- Systemic Lupus Erythematous (SLE)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic Glomerulonephritis Trial (Pioglitazone (ACTOS®),
Not yet recruiting
- ANCA Associated Vasculitis
- +2 more
- Pioglitazone (ACTOS®)
- Placebo of Pioglitazone
- (no location specified)
Jul 7, 2023
IgA Vasculitis Trial in France (Rituximab Injection, )
Recruiting
- IgA Vasculitis
- Rituximab Injection
- placebo
-
Brest, France
- +13 more
Apr 8, 2022
Takayasu Arteritis Trial in China (MMF, CYC, Glucocorticoids)
Active, not recruiting
- Takayasu Arteritis
- MMF
- +4 more
-
Shijiazhuang, Hebei, China
- +6 more
Feb 26, 2022
Systemic Lupus Erythematosus (SLE), Juvenile SLE, Cutaneous Lupus Trial in São Paulo (Thalidomide, Hydroxychloroquine reduced,
Completed
- Systemic Lupus Erythematosus (SLE)
- +2 more
- Thalidomide
- +2 more
-
São Paulo, BrazilHospital das Clinicas da Faculdade de Medicina da USP
Dec 15, 2021
Aneurysm, Behcet Syndrome, Vascular Type Trial in Beijing (tocilizumab, tofacitinib, cyclophosphamide)
Not yet recruiting
- Aneurysm
- Behcet Syndrome, Vascular Type
- tocilizumab
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 26, 2023
Chronic Rhinosinusitis With Nasal Polyps, Glucocorticoids Trial in Beijing (Oral Glucocorticoids, Oral )
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Glucocorticoids
- Oral Glucocorticoids
- Oral placebo
-
Beijing, Beijing, ChinaBeijing Tongren Hospital, Capital Medical University
Oct 25, 2022
Tumor Metastasis, CNS Metastases Trial in Albuquerque (Intensity Modulated Radiotherapy)
Completed
- Neoplasm Metastasis
- Central Nervous System Metastases
- Intensity Modulated Radiotherapy
-
Albuquerque, New MexicoUniverstiy of New Mexico Comprehensive Cancer Center
Apr 21, 2022
Graves Disease, Graves Ophthalmopathy, Liver Diseases Trial (every week IVMP therapy, very high doses IVMP therapy)
Completed
- Graves Disease
- +13 more
- every week IVMP therapy
- very high doses IVMP therapy
- (no location specified)
Sep 11, 2018
SLE (Systemic Lupus) Trial in Niort (data record)
Completed
- SLE (Systemic Lupus)
- data record
-
Niort, FranceCH Niort
Nov 17, 2022
Fractures, Bone, Fractures, Closed, Radius Fracture Distal Trial in Indianapolis (Dexamethasone, Methylprednisolone, Standard of
Active, not recruiting
- Fractures, Bone
- +2 more
- Dexamethasone
- +2 more
-
Indianapolis, IndianaIndiana Hand to Shoulder Center
Dec 14, 2022
Oral Ulcer Trial in Beijing (Lenalidomide 10 mg)
Not yet recruiting
- Oral Ulcer
- Lenalidomide 10 mg
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 5, 2022
Dermatomyositis, Adult Type, Interstitial Lung Disease Trial in Nanjing (triple therapy, dual-therapy)
Recruiting
- Dermatomyositis, Adult Type
- Interstitial Lung Disease
- triple therapy
- dual-therapy
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
May 20, 2022
Sepsis, Severe, Septic Shock Trial in Lakewood, Toms River (Ascorbic Acid, Thiamine, Hydrocortisone)
Completed
- Sepsis, Severe
- Septic Shock
- Ascorbic Acid
- +3 more
-
Lakewood, New Jersey
- +1 more
Aug 25, 2021
Corticosteroid Duration on SARS-CoV-2 (COVID-19 WHO)
Recruiting
- Covid 19
-
Dallas, TexasMethodist Dallas Medical Center
Oct 21, 2022
Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)
Recruiting
- Safety and Efficacy
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Sep 27, 2023
Chronic Pulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis Trial in Chandigarh (Prednisone tablet and
Active, not recruiting
- Chronic Pulmonary Aspergillosis
- Allergic Bronchopulmonary Aspergillosis
- Prednisone tablet and Itraconazole
- Oral itraconazole
-
Chandigarh, India
- +1 more
Jul 1, 2022
SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)
Recruiting
- SLE (Systemic Lupus)
- +4 more
- CD19 targeted CAR-T cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Sep 25, 2023